Jinglei Qu

1.5k total citations
50 papers, 1.1k citations indexed

About

Jinglei Qu is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Jinglei Qu has authored 50 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Oncology, 22 papers in Molecular Biology and 14 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Jinglei Qu's work include Gastric Cancer Management and Outcomes (12 papers), Colorectal Cancer Treatments and Studies (8 papers) and Hepatocellular Carcinoma Treatment and Prognosis (6 papers). Jinglei Qu is often cited by papers focused on Gastric Cancer Management and Outcomes (12 papers), Colorectal Cancer Treatments and Studies (8 papers) and Hepatocellular Carcinoma Treatment and Prognosis (6 papers). Jinglei Qu collaborates with scholars based in China, United States and United Kingdom. Jinglei Qu's co-authors include Xiujuan Qu, Yunpeng Liu, Kezuo Hou, Ling Xu, Xiaofang Che, Yuee Teng, Ye Zhang, Zhi Li, Jingdong Zhang and Yibo Fan and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and FEBS Letters.

In The Last Decade

Jinglei Qu

48 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jinglei Qu China 19 611 469 297 213 183 50 1.1k
Fabiana Conciatori Italy 17 743 1.2× 463 1.0× 309 1.0× 179 0.8× 184 1.0× 23 1.2k
Jean‐Claude Cutz Canada 20 666 1.1× 403 0.9× 319 1.1× 370 1.7× 104 0.6× 45 1.1k
Alessandra Leone Italy 22 934 1.5× 412 0.9× 312 1.1× 212 1.0× 109 0.6× 38 1.4k
Sanchita Rauth United States 18 558 0.9× 378 0.8× 204 0.7× 118 0.6× 171 0.9× 36 962
Jun Ren China 19 674 1.1× 293 0.6× 423 1.4× 269 1.3× 147 0.8× 77 1.1k
Jiliang Shen China 13 644 1.1× 259 0.6× 353 1.2× 201 0.9× 111 0.6× 29 1.1k
Xuenong Ouyang China 16 484 0.8× 395 0.8× 211 0.7× 239 1.1× 96 0.5× 53 894
Shu Zhao China 21 490 0.8× 785 1.7× 409 1.4× 337 1.6× 239 1.3× 43 1.4k
Xiaofang Xing China 23 901 1.5× 309 0.7× 370 1.2× 209 1.0× 214 1.2× 60 1.3k
Clara Campàs Spain 16 773 1.3× 385 0.8× 211 0.7× 131 0.6× 161 0.9× 20 1.2k

Countries citing papers authored by Jinglei Qu

Since Specialization
Citations

This map shows the geographic impact of Jinglei Qu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jinglei Qu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jinglei Qu more than expected).

Fields of papers citing papers by Jinglei Qu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jinglei Qu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jinglei Qu. The network helps show where Jinglei Qu may publish in the future.

Co-authorship network of co-authors of Jinglei Qu

This figure shows the co-authorship network connecting the top 25 collaborators of Jinglei Qu. A scholar is included among the top collaborators of Jinglei Qu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jinglei Qu. Jinglei Qu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
Liu, Chuan, Chuan Hu, Jiale Huang, et al.. (2021). A Prognostic Nomogram of Colon Cancer With Liver Metastasis: A Study of the US SEER Database and a Chinese Cohort. Frontiers in Oncology. 11. 591009–591009. 16 indexed citations
4.
5.
Xu, Lu, Jinglei Qu, Na Song, et al.. (2021). FEN1 is a prognostic biomarker for ER+ breast cancer and associated with tamoxifen resistance through the ERα/cyclin D1/Rb axis. Annals of Translational Medicine. 9(3). 258–258. 17 indexed citations
6.
Yu, Ping, Mingyi Zhou, Jinglei Qu, et al.. (2018). The dynamic monitoring of CEA in response to chemotherapy and prognosis of mCRC patients. BMC Cancer. 18(1). 1076–1076. 13 indexed citations
7.
Wen, Ti, Zhenning Wang, Yi Li, et al.. (2017). A Four-Factor Immunoscore System That Predicts Clinical Outcome for Stage II/III Gastric Cancer. Cancer Immunology Research. 5(7). 524–534. 46 indexed citations
8.
Song, Na, Xiujuan Qu, Shizhou Liu, et al.. (2017). Dual inhibition of MET and SRC kinase activity as a combined targeting strategy for colon cancer. Experimental and Therapeutic Medicine. 14(2). 1357–1366. 6 indexed citations
9.
Zhou, Ming-Yi, Ping Yu, Jinglei Qu, et al.. (2016). Efficacy of Bevacizumab in the First-Line Treatment of Patients with RAS Mutations Metastatic Colorectal Cancer: a Systematic Review and Network Meta-Analysis. Cellular Physiology and Biochemistry. 40(1-2). 361–369. 23 indexed citations
10.
Wang, Jin, Jinglei Qu, Zhi Li, et al.. (2016). A Prognostic Model in Metastatic or Recurrent Gastric Cancer Patients with Good Performance Status Who Received First-Line Chemotherapy. Translational Oncology. 9(3). 256–261. 17 indexed citations
11.
12.
Qu, Xiujuan, Zhi Li, Jinglei Qu, et al.. (2015). Secreted protein acidic and rich in cysteine antagonizes bufalin-induced apoptosis in gastric cancer cells. Molecular Medicine Reports. 12(2). 2926–2932. 10 indexed citations
13.
Qu, Xiujuan, Yibo Fan, Xiaofang Che, et al.. (2013). Trastuzumab and oxaliplatin exhibit a synergistic antitumor effect in HER2-postive gastric cancer cells. Anti-Cancer Drugs. 25(3). 315–322. 12 indexed citations
14.
Zhang, Guodong, Jing Liu, Ye Zhang, et al.. (2012). Cbl‐b‐dependent degradation of FLIPL is involved in ATO‐induced autophagy in leukemic K562 and gastric cancer cells. FEBS Letters. 586(19). 3104–3110. 18 indexed citations
15.
Xu, Ling, Ye Zhang, Jing Liu, et al.. (2012). TRAIL-activated EGFR by Cbl-b-regulated EGFR redistribution in lipid rafts antagonises TRAIL-induced apoptosis in gastric cancer cells. European Journal of Cancer. 48(17). 3288–3299. 47 indexed citations
16.
Zhang, Lingyun, Yuee Teng, Ye Zhang, et al.. (2012). c‐Src expression is predictive of poor prognosis in breast cancer patients with bone metastasis, but not in patients with visceral metastasis. Apmis. 120(7). 549–557. 13 indexed citations
17.
Zhang, Lingyun, Yuee Teng, Ye Zhang, et al.. (2011). C-Src-mediated RANKL-induced breast cancer cell migration by activation of the ERK and Akt pathway. Oncology Letters. 3(2). 395–400. 44 indexed citations
18.
Liu, Jing, Ye Zhang, Jinglei Qu, et al.. (2011). β-Elemene-induced autophagy protects human gastric cancer cells from undergoing apoptosis. BMC Cancer. 11(1). 183–183. 119 indexed citations
19.
Qu, Jinglei, Mingfang Zhao, Ye Zhang, et al.. (2011). Interferon-α sensitizes human gastric cancer cells to TRAIL-induced apoptosis via activation of the c-CBL-dependent MAPK/ERK pathway. Cancer Biology & Therapy. 12(6). 494–502. 29 indexed citations
20.
Qu, Jinglei, Xiujuan Qu, Mingfang Zhao, et al.. (2009). The role of cbl family of ubiquitin ligases in gastric cancer exosome-induced apoptosis of Jurkat T cells. Acta Oncologica. 48(8). 1173–1180. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Fabiana Conciatori Breakdown of academic impact, for papers by Jean‐Claude Cutz Breakdown of academic impact, for papers by Alessandra Leone Breakdown of academic impact, for papers by Sanchita Rauth Breakdown of academic impact, for papers by Jun Ren Breakdown of academic impact, for papers by Jiliang Shen Breakdown of academic impact, for papers by Xuenong Ouyang Breakdown of academic impact, for papers by Shu Zhao Breakdown of academic impact, for papers by Xiaofang Xing Breakdown of academic impact, for papers by Clara Campàs
Rankless by CCL
2026